Test analyzing cells’ ability to fix different kinds of broken DNA could help doctors predict cancer risk.

Meaningful “quick read” whitepaper “Life Science Trends 2014” also offers exclusive feature article on Big Data in the Life Sciences.

The Broad Institute announced April 15 that the United States Patent and Trademark Office has issued the first patent for an engineered CRISPR-Cas9 system that is enabling scientists to modify genes and better understand the biology of living cells and organisms. The institute applied for the patent in concert with the January 3, 2013 publication in Science (Cong, et al.) that described the use of the CRISPR enzyme, Cas9, for genome editing.

Scientists at the Salk Institute have created a new model of memory that explains how neurons retain select memories a few hours after an event.

Scientists have identified two unlikely partners in a type of immune cell called a macrophage that work together in response to cancer drugs to increase inflammation in a way that may alter tumor growth. Researchers from the National Institutes of Health published the study in the journal Cancer Research.

Neuroscientists identify a brain circuit that’s key to shifting our focus from one object to another.

Scientists reported yesterday (Apr. 10) the first human recipients of laboratory-grown vaginal organs. A research team led by Anthony Atala, M.D., director of Wake Forest Baptist Medical Center’s Institute for Regenerative Medicine, describes in the Lancet long-term success in four teenage girls who received vaginal organs that were engineered with their own cells.

When Wayne State University’s team began Phase II of its Chemistry building renovation, it was stumped by a seemingly simple question. Use a single blade damper terminal or a Venturi air valve technology to control its laboratory ventilation and exhaust system?

A Florida State University scientist is part of a team of researchers that has developed a non-invasive way to "light up" animal cells, a development that could significantly advance cell-based therapies and pave the way for more effective cancer research in the long run.

As stem cells continue their gradual transition from the lab to the clinic, a research group at the University of Wisconsin-Madison has discovered a new way to make large concentrations of skeletal muscle cells and muscle progenitors from human stem cells.

Indiana University plays key role in consortium; 1,468 new genes discovered.

Using a powerful data-crunching technique, Johns Hopkins researchers have sorted out how a protein keeps defective genetic material from gumming up the cellular works. The protein, Dom34, appears to “rescue” protein-making factories called ribosomes when they get stuck obeying defective genetic instructions, the researchers report in the Feb. 27 issue of Cell.